Tag: FDA’s flexibility in assessing smoking cessation therapies
FDA Shows Flexibility in Evaluating Smoking Cessation Treatments for Public Meeting
The Food and Drug Administration (FDA) is making changes to how it evaluates new treatments to help people quit smoking. This week, the FDA, along with the National Institutes of Health, published a perspective...